We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Sep 2021
  • Code : CMI4646
  • Pages : 189
  • Formats :
      Excel/PDF
  • Industry : Pharmaceutical

Vasopressin is a nonapeptide produced in the hypothalamus, exhibits diverse physiological functions related to hemodynamic modulation, diuresis, and behavior. Vasopressin is similar to oxytocin, differing in the third and eight amino acid.

Vasopressin is indicated for the treatment of postoperative abdominal distention, abdominal roentgenography, Gastrointestinal Bleeding and diabetes insipidus.

Market Dynamics

The increasing approvals of vasopressin drug by regulatory authorities is expected to drive the global vasopressin market growth. For instance, in 2018, Eagle Pharmaceuticals, Inc., received abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration for its vasopressin injection, 1ml. Vasostrict had around US$ 400 million in brand sales in 2017, according to the Eagle Pharmaceuticals, Inc., company financial review.

Key features of the study:

  • This report provides in-depth analysis of the global vasopressin market, provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global vasopressin market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Par Pharmaceutical, Pfizer Inc., Novartis AG, Ferring Pharmaceuticals, Fresenius Kabi Canada, Astellas Pharma, Shanghai Soho-Yiming Pharmaceuticals, Endo International, Hybio Pharmaceutical, Hainan Zhonghe Pharmaceutical, and Cumberland Pharmaceuticals
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global vasopressin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vasopressin market

Detailed Segmentation:

  • Global Vasopressin Market, By Type:
    • Intravenous Injection
    • Intramuscular Injection
    • Subcutaneous Injection
  • Global Vasopressin Market, By Application:
    • Anti-Diuretic Hormone Deficiency
    • Gastrointestinal Bleeding
    • Vasodilatory Shock
    • Ventricular Tachycardia & Fibrillation
  • Global Vasopressin Market, By End User:
    • Hospital
    • Clinics
    • Others
  • Global Vasopressin Market, By Region:
    • North America
      • By Type
        • Intravenous Injection
        • Intramuscular Injection
        • Subcutaneous Injection
      • By Application
        • Anti-Diuretic Hormone Deficiency
        • Gastrointestinal Bleeding
        • Vasodilatory Shock
        • Ventricular Tachycardia & Fibrillation
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Type
        • Intravenous Injection
        • Intramuscular Injection
        • Subcutaneous Injection
      • By Application
        • Anti-Diuretic Hormone Deficiency
        • Gastrointestinal Bleeding
        • Vasodilatory Shock
        • Ventricular Tachycardia & Fibrillation
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Type
        • Intravenous Injection
        • Intramuscular Injection
        • Subcutaneous Injection
      • By Application
        • Anti-Diuretic Hormone Deficiency
        • Gastrointestinal Bleeding
        • Vasodilatory Shock
        • Ventricular Tachycardia & Fibrillation
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Type
        • Intravenous Injection
        • Intramuscular Injection
        • Subcutaneous Injection
      • By Application
        • Anti-Diuretic Hormone Deficiency
        • Gastrointestinal Bleeding
        • Vasodilatory Shock
        • Ventricular Tachycardia & Fibrillation
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Type
        • Intravenous Injection
        • Intramuscular Injection
        • Subcutaneous Injection
      • By Application
        • Anti-Diuretic Hormone Deficiency
        • Gastrointestinal Bleeding
        • Vasodilatory Shock
        • Ventricular Tachycardia & Fibrillation
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Type
        • Intravenous Injection
        • Intramuscular Injection
        • Subcutaneous Injection
      • By Application
        • Anti-Diuretic Hormone Deficiency
        • Gastrointestinal Bleeding
        • Vasodilatory Shock
        • Ventricular Tachycardia & Fibrillation
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Region/Country
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Par Pharmaceutical*
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Pfizer Inc.
    • Novartis AG
    • Ferring Pharmaceuticals
    • Fresenius Kabi Canada
    • Astellas Pharma
    • Shanghai Soho-Yiming Pharmaceuticals
    • Endo International
    • Hybio Pharmaceutical
    • Hainan Zhonghe Pharmaceutical
    • Cumberland Pharmaceuticals

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Drivers
    • Restraints
    • Opportunities
    • Impact Analysis
    • Key Developments
    • New Product Launches
    • Market Trends
    • Brand Analysis
    • Regulatory Scenario
    • PEST Analysis
  4. Global Vasopressin Market – Impact of Coronavirus (Covid-19) Pandemic
    • COVID-19 Epidemiology
    • Impact on Overall Market
  5. Global Vasopressin Market, By Type, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Intravenous Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Intramuscular Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Subcutaneous Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
  6. Global Vasopressin Market, By Application, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Anti-Diuretic Hormone Deficiency
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Gastrointestinal Bleeding
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Vasodilatory Shock
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Ventricular Tachycardia & Fibrillation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
  7. Global Vasopressin Market, By End User, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
  8. Global Vasopressin Market, By Region, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2028
    • North America
      • Market Size and Forecast, By Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Application, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Application, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Application, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Application, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Application, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Application, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Region/Country, 2021 – 2028, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Competitive Snapshot
      • Par Pharmaceutical
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Pfizer Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Ferring Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Fresenius Kabi Canada
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Astellas Pharma
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Shanghai Soho-Yiming Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Endo International
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hybio Pharmaceutical
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hainan Zhonghe Pharmaceutical
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cumberland Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 32 figures on "Global Vasopressin Market” - Global forecast to 2028

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.